Fed officials say debt downgrade complicates inflation outlook, Nvidia CEO discusses China chip ban, JPMorgan’s investor day, ...

World shares experienced a rally following China's decision to cut key interest rates in response to economic challenges ...

Regeneron Pharmaceuticals is set to acquire 23andMe for $256 million following its bankruptcy filing due to declining demand ...

The US’s credit rating took a hit on Friday, after Moody’s downgraded the country’s AAA rating. And then yesterday, bond prices followed suit. Here to explain the significance of these market moves is ...

Mufg Securities Americas Inc. made a modest splash in the biotech pool, acquiring 1,554 shares of Regeneron Pharmaceuticals ...

The Moody’s announcement sent the yield on a 30-year Treasury bond to a high of 5.01% at one point on Monday. Bond yields ...

Regeneron Pharmaceuticals on Monday said it would buy genetic testing company 23andMe, which filed for bankruptcy in March ...

STORY: Regeneron Pharmaceuticals said on Monday it will buy genetic testing firm 23andMe Holding for $256 million through a ...

The private equity owner of Northwind Midstream is exploring a potential sale of the Permian Basin gas infrastructure ...

Regeneron to rescue 23andMe in a $256 million deal, raising major questions about DNA privacy, genetic data ownership, and ...

Dow Jones Top Company Headlines at 11 AM ET: Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million | JPMorgan ... The move raises privacy concerns as the drugmaker takes control of the genetic ...

The FTSE 100 , US markets and European stocks floundered on Monday, despite a new deal struck between the EU and UK, as ...